Ricardo Santos de Oliveira

Ricardo Santos de Oliveira

Auto-generated profile, based on publicly available information

Ricardo Santos de Oliveira

Division of Neurosurgery, Department of Surgery and Anatomy, University Hospital, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 March 2019 in Acta Neuropathologica Communications
Verified
Journal Article
Open access
PDF file
GCGustavo Alencastro Veiga Cruzeiro
Gustavo Alencastro Veiga Cruzeiro
KSKarina Bezerra Salomão
Karina Bezerra Salomão
CJCarlos Alberto Oliveira de Biagi Junior
Carlos Alberto Oliveira de Biagi Junior
MBMartin Baumgartner
Martin Baumgartner
DSDominik Sturm
Dominik Sturm
Elvis Terci ValeraElvis Terci Valera
Elvis Terci Valera
Next-generation sequencing platforms are routinely used for molecular assignment due to their high impact for risk stratification and prognosis in medulloblastomas. Yet, low and middle-income countries still lack an accurate cost-effective platform to perform this allocation. TaqMan Low Density array (TLDA) assay was performed using a set of 20 genes in 92 medulloblastoma samples. The same methodology was assessed in silico using microarray data for 763 medulloblastoma samples from the GSE85217 study, which performed MB classification by a robust integrative method (Transcriptional, Methylation and cytogenetic profile). Furthermore, we validated in 11 MBs samples our proposed method by Methylation Array 450 K to assess methylation profile along with 390 MB samples (GSE109381) and copy number variations. TLDA with only 20 genes accurately assigned MB samples into WNT, SHH, Group 3 and Group 4 using Pearson distance with the average-linkage algorithm and showed concordance with molecular assignment provided by Methylation Array 450 k. Similarly, we tested this simplified set of gene signatures in 763 MB samples and we were able to recapitulate molecular assignment with an accuracy of 99.1% (SHH), 94.29% (WNT), 92.36% (Group 3) and 95.40% (Group 4), against 97.31, 97.14, 88.89 and 97.24% (respectively) with the Ward.D2 algorithm. t-SNE analysis revealed a high level of concordance (k = 4) with minor overlapping features between Group 3 and Group 4. Finally, we condensed the number of genes to 6 without significantly losing accuracy in classifying samples into SHH, WNT and non-SHH/non-WNT subgroups. Additionally, we found a relatively high frequency of WNT subgroup in our cohort, which requires further epidemiological studies. TLDA is a rapid, simple and cost-effective assay for classifying MB in low/middle income countries. A simplified method using six genes and restricting the final stratification into SHH, WNT and non-SHH/non-WNT appears to be a very interesting approach for rapid clinical decision-making.

15 April 2023 in Acta Neurochirurgica
Verified
Journal Article
Closed access
PDF file
MBMatheus Ballestero
Matheus Ballestero
CDCeleste Dias
Celeste Dias
IGInês Catarina Neves Gomes
Inês Catarina Neves Gomes
LGLuca Soares Grisi
Luca Soares Grisi
RCRodrigo Augusto Monteiro Cardoso
Rodrigo Augusto Monteiro Cardoso
RORicardo Santos de Oliveira
Ricardo Santos de Oliveira

18 October 2018 in Child's Nervous System
Verified
Journal Article
Closed access
PDF file
GPGuilherme Gozzoli Podolsky-Gondim
Guilherme Gozzoli Podolsky-Gondim
LFLuciano Lopes Furlanetti
Luciano Lopes Furlanetti
DVDinark Conceição Viana
Dinark Conceição Viana
MBMatheus Fernando Manzolli Ballestero
Matheus Fernando Manzolli Ballestero
RORicardo Santos de Oliveira
Ricardo Santos de Oliveira

9 October 2019 in Neurological Sciences
Verified
Journal Article
Closed access
PDF file
JMJerônimo Buzetti Milano
Jerônimo Buzetti Milano
ABAlécio Cristino Evangelista Santos Barcelos
Alécio Cristino Evangelista Santos Barcelos
FOFranz Jooji Onishi
Franz Jooji Onishi
JDJefferson Walter Daniel
Jefferson Walter Daniel
RBRicardo Vieira Botelho
Ricardo Vieira Botelho
AJAndrei Fernandes Joaquim
Andrei Fernandes Joaquim

3 October 2013 in Child's Nervous System
Verified
Journal Article
Closed access
PDF file
Elvis Terci ValeraElvis Terci Valera
Elvis Terci Valera
SFSabrine Teixeira Ferraz
Sabrine Teixeira Ferraz
MBMaría Sol Brassesco
María Sol Brassesco
XZXiumei Zhen
Xiumei Zhen
YSYiping Shen
Yiping Shen
LTLuiz Gonzaga Tone
Luiz Gonzaga Tone

22 April 2020 in Scientific Reports
Verified
Journal Article
Open access
PDF file
PKPaulo Henrique dos Santos Klinger
Paulo Henrique dos Santos Klinger
LDLara Elis Alberici Delsin
Lara Elis Alberici Delsin
GCGustavo Alencastro Veiga Cruzeiro
Gustavo Alencastro Veiga Cruzeiro
AAAugusto Faria Andrade
Augusto Faria Andrade
Régia Caroline Caroline Peixoto LiraRégia Caroline Caroline Peixoto Lira
Régia Caroline Caroline Peixoto Lira
Elvis Terci ValeraElvis Terci Valera
Elvis Terci Valera
We evaluated the potential effects of ATO in different pediatric SHH-MB cell lines (ONS-76: TP53-wild type; DAOY and UW402: TP53-mutated). MB cell lines molecular subgroup was confirmed and TP53 mutations were validated. Cell viability, clonogenicity and apoptosis were evaluated after ATO treatment at different concentrations (1–16 µM) alone or combined with irradiation doses (0.5, 1, 2 and 4 Gy). Rad51 and Ku86 proteins were evaluated by WB. ATO treatment reduced cell viability for all SHH-MB cell lines. Significant decrease of clonogenic capacity and higher apoptosis rates were also observed after ATO exposure, being cell death more pronounced (>70%) for the SHH-MB TP53-mutated. Combined treatment of ATO with irradiation also reduced colonies formation in UW402 tumor cells, which was independent of DNA damage repair proteins Rad51 and Ku86. In silico analyses suggested that a set of genes from cell cycle and p53 pathways are differentially expressed in SHH tumor subtypes, suggesting that cell lines may respond to therapies according to the gene expression profiles. Herein, we showed ATO cytotoxicity in pediatric SHH cell lines, with marked radiosensitizing effect for the MB-SHH TP53-mutated cells. These results highlight the potential of ATO, alone or in combination with radiotherapy, supporting further clinical investigations.